Zobrazeno 1 - 10
of 14
pro vyhledávání: '"James K. Aikins"'
Autor:
Michelle Bilbao, Chelsea Katz, Stephanie L. Kass, Devon Smith, Krystal Hunter, David Warshal, James K. Aikins, Olga Ostrovsky
Publikováno v:
Biomolecules, Vol 11, Iss 11, p 1711 (2021)
Recurrent high-grade serous ovarian cancer (HGSC) is clinically very challenging and prematurely shortens patients’ lives. Recurrent ovarian cancer is characterized by high tumor heterogeneity; therefore, it is susceptible to epigenetic therapy in
Externí odkaz:
https://doaj.org/article/c185411d397447509a2c8b6b0faa58f5
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 766, p 766 (2021)
Biomolecules, Vol 11, Iss 766, p 766 (2021)
The success of cannabinoids with chronic neuropathic pain and anxiety has been demonstrated in a multitude of studies. With the high availability of a non-intoxicating compound, cannabidiol (CBD), an over-the-counter medication, has generated heighte
Publikováno v:
Journal of Clinical Oncology. 40:e18800-e18800
e18800 Background: Anemia is a common preoperative finding that is associated with increased morbidity and mortality in patients with gynecologic cancers. This study identified the prevalence and risk factors associated with anemia in women undergoin
Publikováno v:
Gynecologic Oncology. 162:S102-S103
Objectives: High-grade serous ovarian cancer (HGSOC) is the leading cause of death from gynecological cancer in the US. The majority of patients will present at advanced stage and will recur due to chemoresistance. New therapeutic strategies such as
Publikováno v:
Gynecologic oncology. 161(1)
Ovarian cancer is uncommon in relation to other women's cancer, however, it is associated with a disproportionate number of deaths due to women's cancer. According to the National Institute of Health, only 1.2% of new cancer diagnoses in the United S
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Objective: (1) Determine if sequential administration of standard chemotherapy (paclitaxel and cisplatin, P/C) with epigenetic drugs effectively targets ovarian cancer and limits toxicity to normal cells. (2) Define whether epigenetic treatment can s
Autor:
David P. Warshal, Michelle Bilbao, Devon Smith, Stephanie L. Kass, James K. Aikins, Chelsea Katz, Krystal Hunter, Olga Ostrovsky
Publikováno v:
Biomolecules, Vol 11, Iss 1711, p 1711 (2021)
Biomolecules
Volume 11
Issue 11
Biomolecules
Volume 11
Issue 11
Recurrent high-grade serous ovarian cancer (HGSC) is clinically very challenging and prematurely shortens patients’ lives. Recurrent ovarian cancer is characterized by high tumor heterogeneity
therefore, it is susceptible to epigenetic therapy
therefore, it is susceptible to epigenetic therapy
Publikováno v:
International Journal of Gynecology & Obstetrics. 141:252-254
Autor:
Spencer A. Brown, Leona Chang, Olga Ostrovsky, Jennifer Schweinsburg, James K. Aikins, Krystal Hunter
Publikováno v:
Gynecologic Oncology. 159:28
Autor:
Andie OʼLaughlin, Lindsay Fleischer, William A. Davis, James K. Aikins, Michelle Bilbao, Cosette Gabriel
Publikováno v:
Obstetrics & Gynecology. 135:83S